Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases.

Schulte DM, Paulsen K, Türk K, Brandt B, Freitag-Wolf S, Hagen I, Zeuner R, Schröder JO, Lieb W, Franke A, Nikolaus S, Mrowietz U, Gerdes S, Schreiber S, Laudes M.

Nutr Metab Cardiovasc Dis. 2018 Nov;28(11):1100-1105. doi: 10.1016/j.numecd.2018.06.022. Epub 2018 Jul 4.

PMID:
30143407
2.

Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.

Jüptner M, Flachsbart F, Caliebe A, Lieb W, Schreiber S, Zeuner R, Franke A, Schröder JO.

Lupus. 2018 Apr;27(4):600-609. doi: 10.1177/0961203317735187. Epub 2017 Oct 19.

3.

Tocilizumab and steroid boli for treatment-resistant anterior necrotizing scleritis.

Tode J, Zeuner R, Saeger M, Roider J, Nölle B.

Acta Ophthalmol. 2015 Dec;93(8):e683-4. doi: 10.1111/aos.12720. Epub 2015 Jun 1. No abstract available.

4.

IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans.

Müller N, Schulte DM, Türk K, Freitag-Wolf S, Hampe J, Zeuner R, Schröder JO, Gouni-Berthold I, Berthold HK, Krone W, Rose-John S, Schreiber S, Laudes M.

J Lipid Res. 2015 May;56(5):1034-42. doi: 10.1194/jlr.P052209. Epub 2015 Feb 21.

5.

Clinicians' perceptions of digital vs. paper-based decision support interventions.

Politi MC, Adsul P, Kuzemchak MD, Zeuner R, Frosch DL.

J Eval Clin Pract. 2015 Apr;21(2):175-9. doi: 10.1111/jep.12269. Epub 2014 Oct 16.

PMID:
25318648
6.

Physicians' perceptions of shared decision-making behaviours: a qualitative study demonstrating the continued chasm between aspirations and clinical practice.

Zeuner R, Frosch DL, Kuzemchak MD, Politi MC.

Health Expect. 2015 Dec;18(6):2465-76. doi: 10.1111/hex.12216. Epub 2014 Jun 17.

7.

[Eosinophilia - inflammation, proliferation, reaction. Part 2: Specific diseases].

Balke L, Günther A, Zeuner R, Bewig B.

Dtsch Med Wochenschr. 2014 May;139(22):1175-80. doi: 10.1055/s-0034-1369992. Epub 2014 May 20. Review. German. No abstract available.

PMID:
24845526
8.

[Eosinophilia - inflammation, proliferation, reaction. Part 1: diagnostics].

Balke L, Günther A, Zeuner R, Bewig B.

Dtsch Med Wochenschr. 2014 May;139(20):1053-8. doi: 10.1055/s-0034-1369990. Epub 2014 May 6. Review. German.

PMID:
24801301
9.

B Lymphocyte Stimulator (BLyS) is expressed in human adipocytes in vivo and is related to obesity but not to insulin resistance.

Müller N, Schulte DM, Hillebrand S, Türk K, Hampe J, Schafmayer C, Brosch M, von Schönfels W, Ahrens M, Zeuner R, Schröder JO, Blüher M, Gutschow C, Freitag-Wolf S, Stelmach-Mardas M, Saggau C, Schreiber S, Laudes M.

PLoS One. 2014 Apr 11;9(4):e94282. doi: 10.1371/journal.pone.0094282. eCollection 2014.

10.

Interleukin-6 and tumour necrosis factor-α differentially regulate lincRNA transcripts in cells of the innate immune system in vivo in human subjects with rheumatoid arthritis.

Müller N, Döring F, Klapper M, Neumann K, Schulte DM, Türk K, Schröder JO, Zeuner RA, Freitag-Wolf S, Schreiber S, Laudes M.

Cytokine. 2014 Jul;68(1):65-8. doi: 10.1016/j.cyto.2014.03.004. Epub 2014 Apr 8.

PMID:
24721042
11.

Successful application of belimumab in two patients with systemic lupus erythematosus experiencing a flare during tocilizumab treatment.

Jüptner M, Zeuner R, Schreiber S, Laudes M, Schröder JO.

Lupus. 2014 Apr;23(4):428-30. doi: 10.1177/0961203314520844. Epub 2014 Jan 30.

PMID:
24482144
12.

FabryScan: a screening tool for early detection of Fabry disease.

Arning K, Naleschinski D, Maag R, Biegstraaten M, Kropp P, Lorenzen J, Hollak CE, van Schaik IN, Harten P, Zeuner RA, Binder A, Baron R.

J Neurol. 2012 Nov;259(11):2393-400. doi: 10.1007/s00415-012-6619-y. Epub 2012 Aug 10.

PMID:
22878429
13.

[Pulmonary emergencies in connective tissues disorders and vasculitides].

Schröder JO, Zeuner RA, Bewig B, Both M.

Z Rheumatol. 2012 Jun;71(4):278-87. doi: 10.1007/s00393-011-0916-1. German.

PMID:
22699216
14.

Multilayered Gore-Tex patch for temporary coverage of deep noninfectious corneal defects: surgical procedure and clinical experience.

Rüfer F, Eisenack J, Klettner A, Zeuner R, Hillenkamp J, Westphal G, Roider J, Nölle B.

Am J Ophthalmol. 2011 Apr;151(4):703-713.e2. doi: 10.1016/j.ajo.2010.10.025. Epub 2011 Jan 22.

PMID:
21257144
15.

Biologics as treatment for systemic lupus: great efforts, sobering results, new challenges.

Schröder JO, Zeuner RA.

Curr Drug Discov Technol. 2009 Dec;6(4):252-5. Review.

PMID:
20025592
16.

High dose intravenous immunoglobulin in autoimmune rheumatic disorders.

Zeuner RA, Euler HH, Schroeder JO.

BioDrugs. 1997 Nov;8(5):371-86.

PMID:
18020527
17.

Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus.

Moosig F, Damm F, Knorr-Spahr A, Ritgen M, Zeuner RA, Kneba M, Ernst M, Schröder JO.

Clin Exp Immunol. 2006 Dec;146(3):409-16.

18.

C1qRP (CD93) expression on peripheral blood monocytes in patients with systemic lupus erythematosus.

Moosig F, Fähndrich E, Knorr-Spahr A, Böttcher S, Ritgen M, Zeuner R, Kneba M, Schröder JO.

Rheumatol Int. 2006 Oct;26(12):1109-12. Epub 2006 May 4.

PMID:
16673132
19.

IL-1RA in refractory systemic lupus erythematosus.

Moosig F, Zeuner R, Renk C, Schröder JO.

Lupus. 2004;13(8):605-6.

PMID:
15462491
20.
21.

Regulation of CpG-induced immune activation by suppressive oligodeoxynucleotides.

Klinman DM, Zeuner R, Yamada H, Gursel M, Currie D, Gursel I.

Ann N Y Acad Sci. 2003 Dec;1002:112-23.

PMID:
14751829
22.

Differential signaling by CpG DNA in DCs and B cells: not just TLR9.

Verthelyi D, Zeuner RA.

Trends Immunol. 2003 Oct;24(10):519-22. Review.

PMID:
14552833
23.

Monocyte and granulocyte phagocytosis of Escherichia coil particles in systemic lupus erythematosus is not reduced when compared to healthy controls.

Moosig F, Graf D, Knorr-Spahr A, Zeuner RA, Böttcher S, Schröder JO.

Lupus. 2003;12(6):490-2. No abstract available.

PMID:
12873054
24.

Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis.

Zeuner RA, Verthelyi D, Gursel M, Ishii KJ, Klinman DM.

Arthritis Rheum. 2003 Jun;48(6):1701-7.

25.

Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides.

Zeuner RA, Klinman DM, Illei G, Yarboro C, Ishii KJ, Gursel M, Verthelyi D.

Rheumatology (Oxford). 2003 Apr;42(4):563-9.

PMID:
12649404
26.

One foot away.

Zeuner RA.

N Engl J Med. 2002 Nov 28;347(22):1805. No abstract available.

PMID:
12456864
27.

Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides.

Zeuner RA, Ishii KJ, Lizak MJ, Gursel I, Yamada H, Klinman DM, Verthelyi D.

Arthritis Rheum. 2002 Aug;46(8):2219-24.

28.

[Induration in cervical swelling in a 60-year-old patient with multiple myeloma].

Hübner RH, Zeuner RA, Schröder JO.

Internist (Berl). 2000 Dec;41(12):1412-5. German. No abstract available.

PMID:
11189077
29.

Indurierte zervikale Schwellung bei einer 60-jährigen Patientin mit multiplem Myleom.

Hübner RH, Zeuner RA, Schröder JO.

Internist (Berl). 2000 Nov;41(12):1412-1415. doi: 10.1007/s001080050708. German. No abstract available.

PMID:
28550332
30.
31.

[Cryofibrinogenemia caused by monoclonal antifibrinogen antibodies].

Zeuner RA, Euler HH.

Dtsch Med Wochenschr. 1997 Jun 6;122(23):769. German. No abstract available.

PMID:
9229557
32.

[Cryofibrinogenemia caused by monoclonal anti-fibrinogen antibodies].

Zeuner RA, Béress R, Schröder JO, Gutschmidt HJ, Christophers E, Euler HH.

Dtsch Med Wochenschr. 1996 Sep 6;121(36):1084-9. German.

PMID:
8846753
33.

Monoclonal cryo-antifibrinogenemia.

Euler HH, Zeuner RA, Béress R, Gutschmidt HJ, Christophers E, Schroeder JO.

Arthritis Rheum. 1996 Jun;39(6):1066-9.

PMID:
8651973
34.

[G-CSF in patients with lupus-associated neutropenia and infections].

Schwab UM, Harten P, Zeuner RA, Külper M, Euler HH.

Z Rheumatol. 1996 May-Jun;55(3):174-9. German.

PMID:
8768147
35.

High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study.

Schroeder JO, Zeuner RA, Euler HH, Löffler H.

J Rheumatol. 1996 Jan;23(1):71-5.

PMID:
8838511
36.

Successful application of high dose intravenous immunoglobulins in Sjögren's syndrome associated arthritis.

Zeuner RA, Schroeder JO, Schröder F, Euler HH.

Ann Rheum Dis. 1995 Nov;54(11):936. No abstract available.

37.

Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide.

Euler HH, Schroeder JO, Harten P, Zeuner RA, Gutschmidt HJ.

Arthritis Rheum. 1994 Dec;37(12):1784-94.

PMID:
7986225
38.

Effect of antigen-specific immunoadsorption on antibody kinetics in a rat model.

Zeuner RA, Béress R, Schroeder JO, Euler HH.

Biomater Artif Cells Immobilization Biotechnol. 1993;21(2):199-211.

PMID:
8318612
39.

A randomized trial of plasmapheresis and subsequent pulse cyclophosphamide in severe lupus: design of the LPSG trial.

Euler HH, Schroeder JO, Zeuner RA, Teske E.

Int J Artif Organs. 1991 Oct;14(10):639-46.

PMID:
1748532
40.

[Intensified therapy of severe lupus erythematosus].

Euler HH, Schröder JO, Gutschmidt HJ, Harten P, Stueber F, Zeuner RA, Löffler H.

Dtsch Med Wochenschr. 1991 Jul 12;116(28-29):1081-8. German.

PMID:
2065594

Supplemental Content

Loading ...
Support Center